Basic Search
|
Summaries
|
Advanced SearchViolation Tracker Individual Record
Company: Mallinckrodt LLC
Current Parent Company:
Mallinckrodt
Parent at the Time of the Penalty Announcement:
subscribe to see this data field
Penalty: $35,000,000
Year: 2017
Date: July 11, 2017
Offense Group: healthcare-related offenses
Primary Offense: Controlled Substances Act violation
Secondary Offense: opioid crisis litigation
Mega-Scandal:
Opioid Crisis
Violation Description: Mallinckrodt LLC, a pharmaceutical manufacturer and one of the largest manufacturers of generic oxycodone, agreed to pay $35 million to settle allegations that it violated certain provisions of the Controlled Substances Act that are subject to civil penalties.
Level of Government: federal
Action Type: agency action
Agency: Drug Enforcement Administration
Civil or Criminal Case: civil
HQ Country of Current Parent: Ireland
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data:
(click here)
Archived Source:
(click here)
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the
Update Log.
